888 related articles for article (PubMed ID: 15705783)
1. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
2. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
3. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
[TBL] [Abstract][Full Text] [Related]
4. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
5. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
[TBL] [Abstract][Full Text] [Related]
7. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.
Ghaffari S; Kitidis C; Fleming MD; Neubauer H; Pfeffer K; Lodish HF
Blood; 2001 Nov; 98(10):2948-57. PubMed ID: 11698276
[TBL] [Abstract][Full Text] [Related]
10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
12. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
13. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
14. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
16. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms.
Miller CP; Heilman DW; Wojchowski DM
Blood; 2002 Feb; 99(3):898-904. PubMed ID: 11806992
[TBL] [Abstract][Full Text] [Related]
18. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
19. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
20. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
Sawyer ST; Penta K
J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
